Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic

BACKGROUND: Immunomodulatory therapy (IMT) is often considered for systemic treatment of non-infectious uveitis (NIU). During the evolving coronavirus disease-2019 (COVID-19) pandemic, given the concerns related to IMT and the increased risk of infections, an urgent need for guidance on the manageme...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Br J Ophthalmol
Main Authors: Agrawal, Rupesh, Testi, Ilaria, Lee, Cecilia S, Tsui, Edmund, Blazes, Marian, Thorne, Jennifer E, Okada, Annabelle A, Smith, Justine R, McCluskey, Peter J, Kempen, John H, Tappeiner, Christoph, Agarwal, Manisha, Bodaghi, Bahram, Nguyen, Quan Dong, Gupta, Vishali, De Smet, Marc D, Zierhut, Manfred, Pavesio, Carlos
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2020
Teme:
Clinical Science
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7313529/
https://ncbi.nlm.nih.gov/pubmed/32586933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2020-316776
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki